| Company Name: | Arcadia Resources, Inc. | | Ticker Symbol: | KAD | | | WWW Address: | www.arcadiaresourcesinc.com |
| CEO: | Marvin R. Richardson | | No. of Employees: | 4,229 |
| Common Issue Type: | CS | | Business Description: | Arcadia Resources, Inc. together with its wholly-owned subsidiaries is a national provider of home care, medical staffing, and pharmacy services operating under the service mark Arcadia HealthCare.
|
| | | Industry Information: | HEALTH SERVICES - Home Health Care [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 0.038 |  0.0 | - | - | | 0.04 | 0.04 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 7.3 | 193.3 | 0.74 | -0.08 | 0.00 | 0.0 | 0.0 | 0.48 - 0.03 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 0.04 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 7.3 | mil |
| Latest Shares Outstanding | 193.3 | mil |
| Earnings pS (EPS) | -0.08 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 23,656 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 120.9 | mil |
| Float as % of Shares Outstanding | 68.0 | % |
| Foreign Sales | | mil |
| Domestic Sales | | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 35.40 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 28.1 | % |
| EBITDA Margin | -7.4 | % |
| Pre-Tax Profit Margin | -13.5 | % |
| Assets Turnover | 3.4 | % |
| Return on Assets (ROA) | -50.7 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | 71.6 | % |
| Current Ratio | 0.4 | |
| Leverage Ratio (Assets/Equity) | 0.0 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | -0.14 | $ |
| Cash pS | 0.01 | $ |
| Book-Value pS | 0.00 | $ |
| Tangible Book-Value pS | -0.16 | $ |
| Cash Flow pS | -0.06 | $ |
| Free Cash Flow pS | -0.04 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 0.00 | |
| Price/Tangible Book Ratio | -0.24 | |
| Price/Cash Flow | -0.7 | |
| Price/Free Cash Flow | -0.9 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -0.8 | 99 | 6,054 | 29,818 |
| 4 Weeks | 0.08 | 0.03 | 0.05 | -28.3 | 73 | 14,727 | 294,535 |
| 13 Weeks | 0.12 | 0.03 | 0.12 | -68.3 | 35 | 10,546 | 674,932 |
| 26 Weeks | 0.19 | 0.03 | 0.15 | -74.9 | 28 | 9,023 | 1,145,910 |
| 52 Weeks | 0.48 | 0.03 | 0.41 | -90.8 | 9 | 7,514 | 1,893,569 |
| YTD | 0.37 | 0.03 | - | -87.4 | 14 | 9,624 | 1,636,030 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 0.04 | 0.04 | 0.05 | 0.11 | 0.16 | 0.74 | 0.59 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | -8.82 | 71.9 | -17.62 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 0.00 | NA | 0.00 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -3.9 | -3.9 | -3.4 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | 0.00 | 0.00 | 0.11 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 36.58 |
| Current Ratio | 2.4 |
| Quick Ratio (Acid Test) | 2.1 |
| Liquidity Ratio (Cash) | 0.31 |
| Receivables Turnover | 8.2 |
| Average Collection Period | 44 |
| Working Capital/Equity | -47.7 |
| Working Capital pS | 0.05 |
| Cash-Flow pS | -0.06 |
| Free Cash-Flow pS | -0.05 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 2.07 |
| Financial Leverage Ratio (Assets/Equity) | 0.0 |
| Debt Ratio | 176.8 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 204.2 |
| LT Debt/Total Liabilities | 85.1 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 19.79 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 20.18 |
| Tobin's Q Ratio | 0.28 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | -6.03 |
| Enterprise Value (EV)/Free Cash Flow | -10.22 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | -0.24 |
| Price/Book Ratio - LTM | 0.00 |
| Price/Cash Flow Ratio | -0.7 |
| Price/Free Cash Flow Ratio - LTM | -0.9 |
| Price/Sales Ratio | 0.07 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.20 |
| Current Liabilities pS | 0.04 |
| Tangible Book Value pS - LTM | -0.16 |
| Book Value pS - LTM | 0.00 |
| Capital Invested pS | 0.10 |
| Cash pS - LTM | 0.01 |
| Cash Flow pS - LTM | -0.06 |
| Free Cash Flow pS - LTM | -0.04 |
| Earnings pS (EPS) | -0.08 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -10.29 |
| Free Cash Flow Margin 5YEAR AVG | -5.78 |
| Net Profit Margin | -14.3 |
| Net Profit Margin - 5YEAR AVRG. | -24.5 |
| Equity Productivity | -4.99 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 5.20 |
| Return on Capital Invested (ROCI) | -74.5 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -60.1 |
| Assets Productivity | 3.40 |
| Return on Assets (ROA) | -54.9 |
| Return on Assets (ROA) - 5YEAR AVRG. | -45.2 |
| Gross Profit Margin | 28.1 |
| Gross Profit Margin - 5YEAR AVRG. | 32.8 |
| EBITDA Margin - LTM | -7.4 |
| EBIT Margin - LTM | -9.5 |
| Pre-Tax Profit Margin | -15.2 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -23.3 |
| Effective Tax Rate | -0.2 |
| Effective Tax Rate - 5YEAR AVRG. | -1.0 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 47 |
| Revenue per Employee | 23,656 |
| Net Income per Employee | -3,393 |
| Average Collection Period | 43 |
| Receivables Turnover | 8.2 |
| Day's Inventory Turnover Ratio | 4 |
| Inventory Turnover | 83.5 |
| Inventory/Sales | 0.8 |
| Accounts Payble/Sales | 1.23 |
| Assets/Revenue | 0.29 |
| Net Working Capital Turnover | 10.47 |
| Fixed Assets Turnover | 10.32 |
| Total Assets Turnover | 3.4 |
| Revenue per $ Cash | 46.84 |
| Revenue per $ Plant | 79.84 |
| Revenue per $ Common Equity | -4.99 |
| Revenue per $ Capital Invested | 5.20 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 36.4 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 38.2 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |
